This is a preview of subscription content, log in via an institution to check access.
Notes
National Health Service
National Institute for Health and Care Excellence
see PharmacoEconomics & Outcomes News 771 p37; 803224502
Reference
Kmietowicz Z. Pfizer makes breast cancer drug free while NICE decides its future. BMJ 2017: j2225, No. 357, 8 May 2017. Available from: URL: https://doi.org/10.1136/bmj.j2225
Rights and permissions
About this article
Cite this article
Pfizer makes palbociclib free while NICE awaits evidence. PharmacoEcon Outcomes News 778, 6 (2017). https://doi.org/10.1007/s40274-017-3983-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3983-y